| Oct 28 |
NLS Pharmaceutics regains compliance with Nasdaq
|
| Oct 28 |
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
|
| Oct 21 |
NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence
|
| Oct 15 |
NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
|
| Sep 25 |
NLS Pharmaceutics to conduct reverse share split
|
| Sep 25 |
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
|
| Jul 29 |
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Jul 29 |
NLS Pharmaceutics Signs Binding Term Sheet for Merger With Kadimastem; Shares Rise
|
| Jul 29 |
NLS Pharmaceutics announces binding term sheet to merge with Kadimastem
|
| Jul 29 |
NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
|
